AEHR TEST SYSTEMS (AEHR) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-29

Key Insights

Director Scott Geoffrey Gates disposed of 10,000 shares through a charitable donation to the Charitable Gift Fund, indicating philanthropic activity rather than market-driven selling pressure.
Gates maintains significant beneficial ownership of 40,686 shares directly and 50,000 shares indirectly through spouse, plus additional shares held in trust, demonstrating continued material stake in AEHR.
The transaction includes unvested restricted stock units (RSUs) as noted in the 52,864 share count, suggesting ongoing equity compensation alignment with company performance and executive retention.

Want the newest filings?

This analysis covers the filing from 2026-04-29. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-27

VP Alistair N. Sporck acquired 133 shares of common stock on 04/27/2026 through a tax withholding event (Form Code F), indicating RSU vesting rather than open market purchase, which is routine executive compensation activity.
Following the transaction, Sporck beneficially owns 20,161 shares directly and 5,177 shares indirectly through a trust, demonstrating meaningful personal investment in AEHR with total beneficial ownership of approximately 25,338 shares.
The transaction price of $88.48 per share reflects the stock valuation at the vesting date; this is a non-discretionary tax withholding event rather than a voluntary buy/sell signal, limiting sentiment implications.

Filed: 2026-04-27

Executive VP of Sales & Marketing Vernon Rogers sold 139 shares on 04/27/2026 at $88.48 per share, with the sale representing tax withholding obligations from vesting restricted stock units rather than a discretionary sale.
Rogers maintains significant beneficial ownership of 147,577 shares following the transaction, indicating continued substantial personal investment in the company aligned with shareholder interests.
The transaction represents a routine vesting event for executive compensation rather than a material insider trading activity, suggesting confidence in the company's direction by senior management.

Filed: 2026-04-27

CTO Donald P. Richmond executed a tax-withholding transaction on 102 shares of common stock at $88.48, representing a forced sale to cover RSU vesting taxes rather than a discretionary trade.
Richmond's beneficial ownership stands at 181,410 shares following the transaction, indicating significant personal investment in the company despite the tax-driven sale.
The transaction involves restricted stock units with unvested components, suggesting ongoing equity compensation alignment between executive and shareholder interests.

Filed: 2026-04-27

CEO Gayn Erickson withheld 851 shares at $88.48 per share to satisfy tax obligations on vesting restricted stock units, indicating ongoing equity compensation alignment with the company.
The reporting person maintains significant beneficial ownership of 184,660 shares directly and 197,723 shares indirectly through a trust, demonstrating substantial personal investment in AEHR's success.
This transaction represents a tax-driven withholding event rather than a voluntary sale, which is neutral from a sentiment perspective but shows confidence in holding the equity position.
The filing was executed on 04/27/2026 with restricted stock vesting activity, indicating the CEO's compensation structure includes performance-based equity awards typical for public company leadership.

Filed: 2026-04-27

Chief Operating Officer Adil Engineer executed a vesting event of restricted stock units (RSUs) on 04/27/2026, with 143 shares withheld for tax obligations, resulting in net beneficial ownership of 40,912 shares.
The transaction occurred at an implied price of $88.48 per share based on tax withholding calculations, suggesting the stock was trading at a substantial valuation at the time of vesting.
This is a routine RSU vesting event rather than discretionary insider buying or selling, indicating compensation through equity grants rather than market conviction regarding future stock performance.
The COO's total beneficial ownership of 40,912 shares represents meaningful but not dominant stake in the company, consistent with executive-level compensation practices.

Filed: 2026-04-22

Director Howard T. Slayen donated 1,800 shares to a charitable giving fund on 04/22/2026, indicating a charitable disposition rather than a market sale, which is neutral for stock valuation purposes.
Following the transaction, Slayen maintains a substantial beneficial ownership of 176,528 shares (including unvested RSUs), demonstrating continued confidence and material skin in the game as a director.
The transaction was executed at $0 consideration due to the charitable donation nature, so this is not indicative of insider views on stock valuation or market timing.

Filed: 2026-04-22

EVP Alberto Salamone sold 30,000 shares over two trading days (April 20-21, 2026) at prices ranging from $89.57 to $94.56, reducing his holdings from 93,025 to 48,025 shares, representing a significant 51% reduction in his position.
The timing and volume of these sales suggest a planned divestment rather than isolated transactions, with consistent pricing and equal 15,000-share tranches suggesting potential execution under a Rule 10b5-1 trading plan.
After the sales, Salamone retains 48,025 shares of beneficial ownership, indicating he maintains a meaningful stake in the company despite the substantial reduction, though his confidence level appears diminished.

Filed: 2026-04-22

VP Alistair Sporck sold 2,000 shares at $93.495 per share on 04/22/2026, generating approximately $187,000 in proceeds, indicating a potential desire to diversify or realize gains at current price levels.
Following the transaction, Sporck maintains substantial beneficial ownership of 25,471 shares (5,177 direct shares plus 20,294 held indirectly through a trust), demonstrating continued significant stake in the company despite the sale.
The insider sale at a notably high price point of $93.50 suggests confidence in current valuation, though the modest sale volume (2,000 shares) indicates this is not a major liquidation event by a departing executive.

Filed: 2026-04-22

Director Rhea J. Posedel sold 17,715 shares of AEHR common stock on 04/22/2026 at prices between $95-$100, reducing direct beneficial ownership, which may indicate a reduction in confidence or routine portfolio rebalancing.
Posedel maintains substantial indirect beneficial ownership of 396,375 shares held through a trust, indicating significant long-term commitment to the company despite the recent sales transaction.
The sale of approximately 17,700 shares represents a modest disposition relative to total holdings, suggesting this is a relatively minor transaction rather than a major exit by this director-level insider.

Filed: 2026-04-21

Director Rhea J Posedel sold 8,787 shares at $96.02 per share on April 21, 2026, generating approximately $844,000 in proceeds, representing a significant insider sale.
Post-transaction beneficial ownership shows 62,376 directly held shares plus 396,979 shares held indirectly through a trust, indicating substantial continued stake in the company despite the sale.
The sale occurred at a notably high stock price of $96.02, suggesting the insider may be taking profits during a strong valuation period rather than expressing loss of confidence.
As a Director and 10% owner, this insider transaction is material and could be monitored for patterns; however, the insider retained significant ownership demonstrating continued alignment with shareholders.

Filed: 2026-04-21

Executive VP of Sales & Marketing Vernon Rogers sold 5,000 shares at $90 per share on April 20, 2026, representing a significant insider sale of approximately $450,000
Post-transaction beneficial ownership stands at 147,716 shares, indicating Rogers maintains substantial direct ownership despite the sale, suggesting confidence in company fundamentals
The sale occurs at a relatively high price point ($90), which could signal either profit-taking at favorable valuations or potential concern about near-term stock performance
No derivative securities transactions were reported, and the filing contains unvested restricted stock units, indicating compensation is tied to long-term company performance

Filed: 2026-04-21

Director Scott Geoffrey Gates sold 60,000 shares total on 04/21/2026 at prices of $91 and $95, representing a significant reduction in insider holdings and potentially signaling reduced confidence in near-term stock performance.
The sales were executed through multiple ownership structures (direct, by trust, and by spouse), with Gates retaining 50,686 shares, indicating he still maintains meaningful equity exposure despite the substantial divestment.
The timing and volume of these insider sales (60,000 shares at relatively elevated prices above $90) warrant attention as they could indicate a director's view that current valuation levels present an attractive exit opportunity.

Filed: 2026-04-21

Executive VP of Sales & Marketing Vernon Rogers sold 6,486 shares at $94.09 per share on April 21, 2026, generating approximately $610,000 in proceeds, indicating potential profit-taking or liquidity needs.
Rogers retains 152,716 shares following the transaction, including unvested restricted stock units, demonstrating continued substantial ownership alignment with the company despite the sale.
The sale represents a relatively modest reduction (approximately 4.1%) of Rogers' beneficial ownership position, suggesting measured insider activity rather than a sign of major confidence erosion.
The transaction was executed at a significant stock price level ($94.09), which could reflect positive market sentiment or company performance at the time of the sale.

Filed: 2026-04-20

VP Alistair Sporck acquired 341 shares through restricted stock unit (RSU) vesting on 04/18/2026, with 341 shares withheld for tax obligations at $83.86 per share, indicating standard equity compensation execution rather than discretionary insider buying.
Sporck's total beneficial ownership stands at 20,294 shares directly owned plus 7,177 shares held indirectly through a trust, demonstrating meaningful insider stake but representing a relatively modest position for a VP-level executive.
The transaction was executed through an RSU vesting mechanism (code F) rather than open market purchases, which is routine compensation activity and does not signal insider confidence or concerns about stock valuation.
No derivative securities or options activity is reported in this filing, suggesting the executive's compensation package consists primarily of restricted stock units rather than option grants.

Filed: 2026-04-16

The reporting person, Laura Oliphant, a director of AEHR Test Systems, disposed of 4,665 shares of the company's common stock on April 16, 2026 at a price of $85.5879 per share.
Following the reported transaction, the reporting person still holds 18,432 shares of AEHR Test Systems' common stock, which includes shares subject to unvested restricted stock units.
The sale of a significant number of shares by a director may indicate a change in their outlook or investment strategy for the company.

Filed: 2026-04-16

Insider Rhea J. Posedel, a director of AEHR TEST SYSTEMS, has sold 15,000 shares of common stock at an average price of $80.72 per share.
Following the reported transaction, Posedel still holds a substantial direct ownership of 71,163 shares, as well as an indirect beneficial ownership of 411,979 shares through a trust.
The sale of shares by an insider may indicate a change in their sentiment or confidence in the company's future performance, but the overall substantial ownership position suggests they remain invested in the company.

Filed: 2026-04-15

Didier Wimmers, the Executive VP of R&D at AEHR Test Systems, has sold 5,400 shares of the company's common stock over the past two trading days at average prices of $71.11 and $72.02.
The total number of shares beneficially owned by Wimmers has decreased from 12,559 to 10,659, indicating a reduction in his direct ownership stake in the company.
The insider selling activity may indicate Wimmers' personal financial planning or portfolio diversification, but it does not necessarily reflect the company's overall performance or prospects.

Filed: 2026-04-15

Donald P. Richmond II, the Chief Technical Officer, sold 17,011 shares of AEHR TEST SYSTEMS (AEHR) at an average price of $73.1764 on April 14, 2026.
The transaction reduced Richmond's direct beneficial ownership to 181,512 shares, which includes unvested restricted stock units.
Insider selling can sometimes be a bearish signal, although the significance depends on the overall context and reasons behind the transaction.

Filed: 2026-04-14

The reporting person, Gayn Erickson, who is the President and CEO of AEHR TEST SYSTEMS, disposed of 2,784 shares through a tax withholding transaction, which does not represent a sale.
Erickson still beneficially owns a significant number of shares, including 185,511 shares directly and 197,723 shares indirectly through a trust.
The transaction appears to be a routine personal tax matter and does not indicate any significant change in Erickson's ownership or his confidence in the company.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.